BIRC3 and B-cell chronic lymphocytic leukemia: In order to evaluate how BIRC3 deletion and/or mutation could contribute to CLL clonal dynamics, we next carried out in vitro clonal competition experiments by mixing RFP- or GFP-tagged CRISPR/Cas9-edited cells at a ratio 1:1 and tracked clonal evolution overtime by flow cytometry.